JSC
TMO icon

Jackson Square Capital’s Thermo Fisher Scientific TMO Stock Holding History

Jackson Square Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,000
Closed -$7K – 313
2020
Q3 		$7K Buy
+1,000
New +$413K ﹤0.01% 284

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jackson Square Capital's TMO Position: Q2 2026 in Review

Jackson Square Capital reduced its Thermo Fisher Scientific (TMO) stake by 7.1% in Q2 2026, selling an estimated $155K and leaving 4,215 shares worth $2.11M. The position accounts for 0.29% of the portfolio, ranked #51.

Jackson Square Capital first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.57M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Jackson Square Capital held 4,215 shares of Thermo Fisher Scientific worth $2.11M as of Q2 2026.
  • Jackson Square Capital sold 322 Thermo Fisher Scientific shares in Q2 2026, an estimated $155K.
  • Thermo Fisher Scientific made up 0.29% of Jackson Square Capital's portfolio in Q2 2026, its #51 holding.
  • Jackson Square Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Jackson Square Capital's Thermo Fisher Scientific position peaked at $7.57M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.